Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab
FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab
FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab
Submitted by
admin
on November 10, 2014 - 11:05am
Source:
Yahoo
News Tags:
FDA
Amgen
evolocumab
Headline:
FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab
Do Not Allow Advertisers to Use My Personal information
